Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stephen Tucker, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT00581425
First received: December 21, 2007
Last updated: January 23, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)